Replies to post #13376 on Algernon Pharmaceuticals Inc (AGNPF)

[Money $hot]

MC can you further opine about your belief most data has been reported?

I mean, where in the language received to date brings you to such a conclusion?

Do you know how many endpoints there are?

Do you know how many endpoints are remaining?

It's my interpretation from reading the NR's only 1 endpoint has been partially read.

What say you in EZ to understand terms?

News Release of 12/17/2020

“The Company believes that the interim data represents a very positive step in the investigation of Ifenprodil as a potential therapeutic treatment for COVID-19,” said Christopher J. Moreau, CEO of Algernon Pharmaceuticals. “We were very pleased to see positive trending data with a ventilation related endpoint that is favoured by the FDA for COVID-19 trials. Further, Algernon has only provided interim data on three endpoints from day 15 of its 30-day Phase 2b/3 Ifenprodil COVID-19 study, with the majority of the data still to be reported.”

News Release of 12/15/2020

For the endpoint of ventilation by day 15, there was a trend towards fewer patients requiring mechanical ventilation in the high dose Ifenprodil treatment arm, as compared to patients who were in the untreated arm of the study. Mechanical ventilation is associated with poor prognosis in COVID-19 patients, including increased risk of mortality and procedural complications.(1) In addition, extended duration of mechanical ventilation places an enormous burden on ICUs and entire hospital systems.

In addition to including full statistics, there will be additional key endpoints reported in the final data set of the Phase 2b part of the study that are not in the interim data set, such as time to discharge from the hospital, and time on mechanical ventilation.

On another note. My best guess is those who exercised warrants are dumping for profit before data readout. How low can it go...who the f*** knows? it's all profit down to Sub 10 Cent USD. 12 Cent CAD = 9.4 Cent USD.

M$